These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36251548)

  • 1. Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019.
    Maxson T; Kongphet-Tran T; Mongkolrattanothai T; Travis T; Hendricks K; Parker C; McLaughlin HP; Bugrysheva J; Ambrosio F; Michel P; Cherney B; Lascols C; Sue D
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S373-S378. PubMed ID: 36251548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis of clarithromycin resistance in
    Maxson T; Overholt WA; Chivukula V; Caban-Figueroa V; Kongphet-Tran T; Medina Cordoba LK; Cherney B; Rishishwar L; Conley A; Sue D
    Microbiol Spectr; 2024 Jun; 12(6):e0418023. PubMed ID: 38666793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
    Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG
    Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018.
    Person MK; Cook R; Bradley JS; Hupert N; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S392-S401. PubMed ID: 36251553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.
    Bower WA; Yu Y; Person MK; Parker CM; Kennedy JL; Sue D; Hesse EM; Cook R; Bradley J; Bulitta JB; Karchmer AW; Ward RM; Cato SG; Stephens KC; Hendricks KA
    MMWR Recomm Rep; 2023 Nov; 72(6):1-47. PubMed ID: 37963097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.
    Parker CM; Karchmer AW; Fisher MC; Muhammad KM; Yu PA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S417-S431. PubMed ID: 36251549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of
    Manzulli V; Fasanella A; Parisi A; Serrecchia L; Donatiello A; Rondinone V; Caruso M; Zange S; Tscherne A; Decaro N; Pedarra C; Galante D
    J Vet Sci; 2019 Jan; 20(1):58-62. PubMed ID: 30541185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of anthrax meningitis.
    Sejvar JJ; Tenover FC; Stephens DS
    Lancet Infect Dis; 2005 May; 5(5):287-95. PubMed ID: 15854884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):960. PubMed ID: 11708594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole Genome Analysis of Injectional Anthrax Identifies Two Disease Clusters Spanning More Than 13 Years.
    Keim P; Grunow R; Vipond R; Grass G; Hoffmaster A; Birdsell DN; Klee SR; Pullan S; Antwerpen M; Bayer BN; Latham J; Wiggins K; Hepp C; Pearson T; Brooks T; Sahl J; Wagner DM
    EBioMedicine; 2015 Nov; 2(11):1613-8. PubMed ID: 26870786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Bacillus anthracis in an endemic area.
    Bakici MZ; Elaldi N; Bakir M; Dökmetaş I; Erandaç M; Turan M
    Scand J Infect Dis; 2002; 34(8):564-6. PubMed ID: 12238569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.
    Hesse EM; Godfred-Cato S; Bower WA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign.
    Shaffer D; Armstrong G; Higgins K; Honig P; Coyne P; Boxwell D; Beitz J; Leissa B; Murphy D
    Pharmacoepidemiol Drug Saf; 2003; 12(3):177-82. PubMed ID: 12733470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States.
    Hoffmaster AR; Fitzgerald CC; Ribot E; Mayer LW; Popovic T
    Emerg Infect Dis; 2002 Oct; 8(10):1111-6. PubMed ID: 12396925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparedness for an anthrax attack.
    Franz DR
    Mol Aspects Med; 2009 Dec; 30(6):503-10. PubMed ID: 19619577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.